# SHENDE

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shende

- Industry: Medical Devices & Equipment
- Headquarters: Shanghai, China
- Website: www.shendehc.com
- Total disclosed funding: $43M
- Latest round: Series D (Oct 10, 2023)
- Investors on record: 17

## About

Established in 2013 and based in Shanghai, China, SHENDE is a research and development company of ultrasound precision non-invasive tumor ablation equipment. The company holds nearly 50 patents and software copyrig. In addition, it has a 5,400 square meter intelligent manufacturing plant with an annual capacity of 720 ultrasound precision non-invasive oncology medical devices. It has partnerships with Shanghai Jiaotong University, Shanghai First People's Hospital, Fudan University Cancer Hospital, and Renji Hospital. In October 2023, it raised approximately CNY 200 million in series D funding from new investors Hefei State-Owned Assets Holding, Ningbo Dading Shengye Investment Management, Zhongli Capital and an individual investor.

SHENDE adopts a new generation of MRI-guided phased focused ultrasound technology to provide users with a new non-invasive breast adenoma ultrasound diagnosis and treatment integrated system, a new non-invasive bone tumor advanced pain relief ultrasound treatment device and other products, which are used in treatment diseases such as Parkinson's and brain tumors.

The company will use the series D funding the magnetic wave knife series of new product research and development, clinical, certification, marketing, IPO counseling and global industrial layout, focusing on the promotion of neural knife, prostate knife, ultrasound medical aesthetic products, to promote the construction of subsidiaries in Hefei, Beidaihe and the establishment of European and American subsidiaries to operate.

## Funding rounds

- Series D, Oct 10, 2023, $27M — Hefei State-Owned Assets Holding, Zhongli Capital, Ningbo Dading Shengye Investment Management
- Series C, Nov 30, 2021, $16M — CITIC Securities, Shanghai Xuhui Technology Venture Capital, Shanghai Creation Investment, Chuanghehui Capital, Hunan Xingxiang Investment Holding Group, Rending Investment, Wangying Investment, Anhui Cunmiao Enterprise Management Service Partnership
- Series B, Jul 6, 2021 — Creation Capital, Infore Capital, Solid Wood Investment, Dianshi Fund, Tech Wisdom Capital, Rending Investment
- Series A, Jun 4, 2019 — Medtronic Ventures

## Investors

- Medtronic Ventures (https://capitalatlas.ai/funds/medtronic-ventures) — Series A
- Creation Capital (https://capitalatlas.ai/funds/creation-capital) — Series B
- Infore Capital (https://capitalatlas.ai/funds/infore-capital) — Series B
- Solid Wood Investment (https://capitalatlas.ai/funds/solid-wood-investment) — Series B
- Dianshi Fund (https://capitalatlas.ai/funds/dianshi-fund) — Series B
- Tech Wisdom Capital (https://capitalatlas.ai/funds/tech-wisdom-capital) — Series B
- Rending Investment — Series B, Series C
- CITIC Securities — Series C
- Shanghai Xuhui Technology Venture Capital — Series C
- Shanghai Creation Investment (https://capitalatlas.ai/funds/shanghai-creation-investment) — Series C
- Chuanghehui Capital (https://capitalatlas.ai/funds/chuanghehui-capital) — Series C
- Hunan Xingxiang Investment Holding Group (https://capitalatlas.ai/funds/hunan-xingxiang-investment-holding-group) — Series C
- Wangying Investment — Series C
- Anhui Cunmiao Enterprise Management Service Partnership — Series C
- Hefei State-Owned Assets Holding (https://capitalatlas.ai/funds/hefei-state-owned-assets-holding) — Series D
- Zhongli Capital — Series D
- Ningbo Dading Shengye Investment Management — Series D